Qianglian Zhichuang
Beijing
About Qianglian Zhichuang
the first high-tech company in China to focus on the treatment of cerebrovascular disease, it has more than four years of product research and development, leading China's cerebrovascular disease intelligence in an all-around way. vertical field of diagnosis and treatment. It has become a well-known brain stroke intelligence diagnosis and treatment platform in China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $45.3M
- Funding stage: Late Stage Venture
- Last round: Series D (Oct 2024)
- Website: unionstrongtech.comindex
- Phone: 010-87927329
Industries & Categories
Medical
Canonical: https://fsome.com/organization/qianglian-zhichuang-89228 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.